| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A new “FIX” for hemophilia B gene therapy
|
Almeida-Porada, Graça
|
|
|
137 |
21 |
p. 2860-2861
|
artikel
|
| 2 |
A phase 1 study of a novel fully human BCMA-targeting CAR (CT103A) in patients with relapsed/refractory multiple myeloma
|
Wang, Di
|
|
|
137 |
21 |
p. 2890-2901
|
artikel
|
| 3 |
ATG5 promotes eosinopoiesis but inhibits eosinophil effector functions
|
Germic, Nina
|
|
|
137 |
21 |
p. 2958-2969
|
artikel
|
| 4 |
BCMA CARs in multiple myeloma: room for more?
|
Lee, Lydia Sarah Hui
|
|
|
137 |
21 |
p. 2859-2860
|
artikel
|
| 5 |
Clonal hematopoiesis and therapy-related myeloid neoplasms following neuroblastoma treatment
|
Coorens, Tim H.H.
|
|
|
137 |
21 |
p. 2992-2997
|
artikel
|
| 6 |
Decreased activity and stability of pyruvate kinase in sickle cell disease: a novel target for mitapivat therapy
|
Rab, Minke A.E.
|
|
|
137 |
21 |
p. 2997-3001
|
artikel
|
| 7 |
Discordant solutions to discordant problems
|
Tobin, Joshua W.D.
|
|
|
137 |
21 |
p. 2857-2858
|
artikel
|
| 8 |
Editorial Board
|
|
|
|
137 |
21 |
p. i
|
artikel
|
| 9 |
Factor VIII–antibody structure and membrane binding
|
Gilbert, Gary E.
|
|
|
137 |
21 |
p. 2866-2868
|
artikel
|
| 10 |
Factor VIII/VWF complex caught on camera
|
Xu, Emma-Ruoqi
|
|
|
137 |
21 |
p. 2865-2866
|
artikel
|
| 11 |
Gene therapy for hemophilia B using CB 2679d-GT: a novel factor IX variant with higher potency than factor IX Padua
|
Nair, Nisha
|
|
|
137 |
21 |
p. 2902-2906
|
artikel
|
| 12 |
IGLV3-21R110 identifies an aggressive biological subtype of chronic lymphocytic leukemia with intermediate epigenetics
|
Nadeu, Ferran
|
|
|
137 |
21 |
p. 2935-2946
|
artikel
|
| 13 |
Incidence of skin hyperpigmentation in Black patients receiving treatment with immunomodulatory drugs
|
Milrod, Charles J.
|
|
|
137 |
21 |
p. 2987-2989
|
artikel
|
| 14 |
In CLL, epigenetics also points to the BCR
|
Ghia, Paolo
|
|
|
137 |
21 |
p. 2863-2865
|
artikel
|
| 15 |
Malcovati L, Stevenson K, Papaemmanuil E, et al. SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS. Blood. 2020;136(2):157-170.
|
|
|
|
137 |
21 |
p. 3003
|
artikel
|
| 16 |
Markers of complement activation in plasma during quiescent phases in patients with catastrophic antiphospholipid syndrome
|
Ruffatti, Amelia
|
|
|
137 |
21 |
p. 2989-2992
|
artikel
|
| 17 |
Molecular determinants of the factor VIII/von Willebrand factor complex revealed by BIVV001 cryo-electron microscopy
|
Fuller, James R.
|
|
|
137 |
21 |
p. 2970-2980
|
artikel
|
| 18 |
OBF1 and Oct factors control the germinal center transcriptional program
|
Song, Shuang
|
|
|
137 |
21 |
p. 2920-2934
|
artikel
|
| 19 |
OBF1 and OCT1/2 regulate the germinal center B-cell program
|
Küppers, Ralf
|
|
|
137 |
21 |
p. 2862-2863
|
artikel
|
| 20 |
Plasminogen: an enigmatic zymogen
|
Keragala, Charithani B.
|
|
|
137 |
21 |
p. 2881-2889
|
artikel
|
| 21 |
Posttransplant T lymphoblastic lymphoma mimicking Burkitt lymphoma
|
Mass, Jirong
|
|
|
137 |
21 |
p. 3002
|
artikel
|
| 22 |
Single-cell analysis can define distinct evolution of tumor sites in follicular lymphoma
|
Haebe, Sarah
|
|
|
137 |
21 |
p. 2869-2880
|
artikel
|
| 23 |
Structure of blood coagulation factor VIII in complex with an anti–C1 domain pathogenic antibody inhibitor
|
Gish, Joseph S.
|
|
|
137 |
21 |
p. 2981-2986
|
artikel
|
| 24 |
Targeting Bfl-1 via acute CDK9 inhibition overcomes intrinsic BH3-mimetic resistance in lymphomas
|
Boiko, Scott
|
|
|
137 |
21 |
p. 2947-2957
|
artikel
|
| 25 |
TWIST1 preserves hematopoietic stem cell function via the CACNA1B/Ca2+/mitochondria axis
|
Wang, Nan
|
|
|
137 |
21 |
p. 2907-2919
|
artikel
|
Tijdschrift beschrijving